Image

Global In Situ Hybridization Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 50
  • No of Figures: 250

Global In Situ Hybridization Market, By Technology (Chromogenic In Situ Hybridization (CISH), Fluorescence In Situ Hybridization (FISH)), Application (Immunology, Microbiology, Cancer Diagnostic, Neuroscience and Infectious Diseases), End User (Biotechnology/Pharmaceutical Companies, Academic and Research Institutes, Molecular Diagnostic Labs), Type (DNA, RNA), Product (Instruments, Probes and Kits) – Industry Trends and Forecast to 2029

In Situ Hybridization Market

Global In Situ Hybridization Market Analysis and Size

In recent years, in situ hybridization has found a special place in specialized fields of studies. "In situ" is a Latin term for "in place", and it is utilized for detecting either RNA or DNA in the situation of the cells or actual animals. The increase in the prevalence of cancer is escalating the growth of in situ hybridization market.

  • Global in situ hybridization market was valued at USD 0.90 billion in 2021 and is expected to reach USD 2.40 billion by 2029, registering a CAGR of 11.50% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global In Situ Hybridization Market Definition

In situ hybridization refers to a laboratory technique where a probe used, and the probe is made with DNA or RNA. This probe is single-stranded containing moiety that can detect either chemically or radioactively. Then, single-stranded is hybridized and hybridization part comes in. This technique enables precise localization of a specific segment of nucleic acid within a histologic section.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Technology (Chromogenic In Situ Hybridization (CISH), Fluorescence In Situ Hybridization (FISH)), Application (Immunology, Microbiology, Cancer Diagnostic, Neuroscience and Infectious Diseases), End User (Biotechnology/Pharmaceutical Companies, Academic and Research Institutes, Molecular Diagnostic Labs), Type (DNA, RNA), Product (Instruments, Probes and Kits)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Abbott (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), PerkinElmer Inc. (US), Danaher (US), BioGenex (US), Advanced Cell Diagnostics, Inc. (US), Bio SB (US), Leica Biosystems Nussloch GmbH (Germany), Oxford Gene Technology (UK), Medtronic (Ireland), GENERAL ELECTRIC (US), Siemens (Germany), Koninklijke Philips N.V. (Netherlands), IMRIS (Canada), NeuroLogica Corp. (US) and Ziehm Imaging GmbH (Germany), among others

In Situ Hybridization Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

  • Prevalence of Cancer

The increase in the prevalence of cancer across the globe acts as one of the major factors driving the growth of in situ hybridization market.

  • Funds and Grants

The surge in investments in the form of funds and grants for biomarker research further influence the market growth.

  • Incidence of genetic disorders

The surge in the incidences of genetic disorders among population accelerate the in situ hybridization market growth.

Opportunities

Furthermore, technological advancements in the in situ hybridization technique extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, research and development activities will assist in the expansion of the market.

Restraints/Challenges Global In Situ Hybridization Market

On the other hand, availability of other methods and complications with existing application technologies are expected to obstruct market growth. Also, the lack of skilled professionals is projected to challenge the in situ hybridization market in the forecast period of 2022-2029.

This in situ hybridization market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on in situ hybridization market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on In Situ Hybridization Market

COVID 19 is estimated to have a significant impact on the in situ hybridization market. The use of these methods in the research of the molecular biology of this virus accelerated the demand for the procedures. Pharmaceutical and biotech companies collaborated with government in research associated with the SARS-CoV-2 and related viruses to offer diagnostics and therapy.

Recent Development

  • RNAscope ISH Detection Kit (Bio-Techne) by BOND-III platform (Leica Biosystems) received CE-IVD approval in 2020. RNAscope is known to be a robust technology for identifying localization at the single cell level and RNA expression patterns with morphologic and spatial context.

Global In Situ Hybridization Market Scope and Market Size

The biomarkers market is segmented on the basis of technology, application, end user, type and product. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

  • Chromogenic In Situ Hybridization (CISH)
  • Fluorescence In Situ Hybridization (FISH)

On the basis of technology, the In situ hybridization market is segmented into chromogenic In situ hybridization (CISH) and fluorescence in situ hybridization (FISH). Fluorescence in situ hybridization (FISH) has been further segmented into DNA-FISH and RNA-FISH.

Application

  • Immunology
  • Microbiology
  • Cancer Diagnostic
  • Neuroscience
  • Infectious Diseases

On the basis of application, the In situ hybridization market is segmented into immunology, microbiology, cancer diagnostic and neuroscience and infectious diseases.

End User

  • Biotechnology/Pharmaceutical Companies
  • Academic and Research Institutes
  • Molecular Diagnostic Labs

On the basis end user, the In situ hybridization market is segmented into biotechnology/pharmaceutical companies, academic and research institutes and molecular diagnostic labs.

Type

  • DNA
  • RNA

On the basis of type, the In situ hybridization market is segmented into DNA and RNA.

Product

  • Instruments
  • Probes And Kits

On the basis of product, the In situ hybridization market is segmented into instruments and probes and kits.

In Situ Hybridization Market Regional Analysis/Insights

The in situ hybridization market is analysed and market size insights and trends are provided by country, technology, application, end user, type and product as referenced above.

The countries covered in the in situ hybridization market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the in situ hybridization market because of the increase in the incidence of cancer and infectious diseases within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the surge in research and development investments in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The in situ hybridization market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for in situ hybridization market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the in situ hybridization market. The data is available for historic period 2010-2020.

Competitive Landscape and In Situ Hybridization Market Share Analysis

The in situ hybridization market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to in situ hybridization market.

Some of the major players operating in the in situ hybridization market are Abbott (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), PerkinElmer Inc. (US), Danaher (US), BioGenex (US), Advanced Cell Diagnostics, Inc. (US), Bio SB (US), Leica Biosystems Nussloch GmbH (Germany), Oxford Gene Technology (UK), Medtronic (Ireland), GENERAL ELECTRIC (US), Siemens (Germany), Koninklijke Philips N.V. (Netherlands), IMRIS (Canada), NeuroLogica Corp. (US) and Ziehm Imaging GmbH (Germany), among others.

Research Methodology : Global In Situ Hybridization Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-in-situ-hybridization-market

Customization Available : Global In Situ Hybridization Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The In Situ Hybridization Market is projected at USD 2.40 billion during the forecast period of 2022 to 2029.
The In Situ Hybridization Market is Expected to Witness CAGR of 11.50% During the Forecast Period of 2022 to 2029.
The Major Players Operating in the In Situ Hybridization Market are Abbott (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), PerkinElmer Inc. (US), among others.
The Countries Covered in the In Situ Hybridization Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The In Situ Hybridization Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.